These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 3132497)
1. Thrombolytic therapy and the new environment of medical practice. DeMaria AN J Am Coll Cardiol; 1988 Jul; 12(1):284-5. PubMed ID: 3132497 [No Abstract] [Full Text] [Related]
2. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. de Boer MJ; van Hout BA; Liem AL; Suryapranata H; Hoorntje JC; Zijlstra F Am J Cardiol; 1995 Oct; 76(11):830-3. PubMed ID: 7572666 [No Abstract] [Full Text] [Related]
3. Cost-effectiveness of intravenous thrombolytic drugs for acute myocardial infarction. Naylor CD; Bronskill S; Goel V Can J Cardiol; 1993; 9(6):553-8. PubMed ID: 8221354 [No Abstract] [Full Text] [Related]
4. Current status of thrombolytic therapy in acute myocardial infarction. Dutta AL; Mandal M J Indian Med Assoc; 1991 Nov; 89(11):322-4. PubMed ID: 1787323 [No Abstract] [Full Text] [Related]
5. [Plasminogen activators as thrombolytic agents in myocardial infarction]. Chamone DA; Massumoto C; Fujimura AY; Pileggi F; Bellotti G Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(6):288-94. PubMed ID: 2518605 [TBL] [Abstract][Full Text] [Related]
6. Streptokinase...never again. van de Werf F Eur Heart J; 1999 Sep; 20(17):1215. PubMed ID: 10454969 [No Abstract] [Full Text] [Related]
7. [Thrombolytic therapy and angioplasty in myocardial infarction-- progress in the 1980s]. Twardowski RM Kardiol Pol; 1990; 33(6):345-50. PubMed ID: 2084299 [No Abstract] [Full Text] [Related]
8. [Myocardial infarction treated within 4 hrs: comparison of the cost-benefit ratio of 3 thrombolytic treatments: APSAC, rt-PA and streptokinase in 270 patients]. Machecourt J; Cassagnes J; Bassand JP; Dumoulin J; Calop J; Foroni L; Terrisse MP; Hénon T; Petit L; Denis B Arch Mal Coeur Vaiss; 1993 Feb; 86(2):209-17. PubMed ID: 8363422 [TBL] [Abstract][Full Text] [Related]
9. Thrombolytic therapy in the elderly. Pharmacoeconomic considerations. Ramanathan K; Ellis CJ; White HD Drugs Aging; 1996 Apr; 8(4):237-44. PubMed ID: 8920173 [TBL] [Abstract][Full Text] [Related]